US EditionNew Blood Test Predicts Multiple Sclerosis Years Before Symptoms
VIENNA, AUSTRIA, JUL 14 – The test detects Epstein-Barr virus antibodies that predict multiple sclerosis risk years before symptoms, enabling earlier diagnosis and potential intervention, researchers said.
8 Articles
8 Articles
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titers
Multiple sclerosis (MS) is an immune-mediated demyelinating disease. Epstein-Barr virus (EBV) encodes for the EBNA-1381-452 region that induces autoreactive antibody responses, which are likely critically involved in MS pathogenesis. Here we investigate whether these EBNA-1381-452-specific antibodies can serve as a biomarker to identify at-risk individuals for MS. We quantify EBNA-1381-452-specific antibody titers from 324 relapsing-remitting MS…
New blood test predicts multiple sclerosis years before symptoms
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms.
New blood test predicts multiple sclerosis risk years before symptoms appear
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms. As a result, in the future, diagnostic and therapeutic measures could be taken early enough to delay or even prevent the onset of the disease. The research has just been published in Nature Communications.
Long confined to the discreet role of virus responsible for mononucleosis, the Epstein-Barr virus now returns to the forefront of the scientific scene with a completely different face. Present in the organism of almost all adults, it has for years intrigued researchers who explore the origins of multiple sclerosis. A new, very large-scale study now provides solid evidence for a direct link between this viral infection and the appearance of autoi…
GFAP protein levels may help predict MS disease severity...
Blood levels of a protein called GFAP, which reflects the activation and damage to support cells in the brain and spinal cord, may help predict disease severity and the response […] The post GFAP protein may help predict MS severity, response to treatment appeared first on Multiple Sclerosis News Today.
Newly developed blood tests should enable early detection of multiple sclerosis (MS) - already years before symptoms occur, according to a message from the MedUni Vienna on Monday. A research team at the university has developed tests in which antibodies against a protein of the Epstein-Barr virus (EBV) can be identified. EBV plays a central role in the development and development of MS - in almost all cases an EBV infection can be detected.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
